{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:44:58Z","timestamp":1793400298097,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010586","name":"Haukeland University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010586","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Bergen"},{"DOI":"10.13039\/100007793","name":"Stiftelsen Kristian Gerhard Jebsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Southern and Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009707","name":"Norwegian Diabetes Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009707","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00125-016-4167-1","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T03:58:00Z","timestamp":1480651080000},"page":"625-635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry"],"prefix":"10.1007","volume":"60","author":[{"given":"Bente B.","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik U.","family":"Irgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Molnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Sztromwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petur B.","family":"Juliusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oddmund","family":"S\u00f8vik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torild","family":"Skrivarhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Joner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Molven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l R.","family":"Nj\u00f8lstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"issue":"suppl. 20","key":"4167_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/pedi.12192","volume":"15","author":"O Rubio-Cabezas","year":"2014","unstructured":"Rubio-Cabezas O, Hattersley AT, Njolstad PR et al (2014) ISPAD clinical practice consensus guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 15(suppl 20):47\u201364","journal-title":"Pediatr Diabetes"},{"key":"4167_CR2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/erm.10.123","volume":"11","author":"A Molven","year":"2011","unstructured":"Molven A, Njolstad PR (2011) Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev Mol Diagn 11:313\u2013320","journal-title":"Expert Rev Mol Diagn"},{"key":"4167_CR3","first-page":"55","volume":"2013","author":"O S\u00f8vik","year":"2013","unstructured":"S\u00f8vik O, Irgens HU, Molnes J et al (2013) Monogenic diabetes mellitus in Norway. Norsk Epidemiol 2013:55\u201360","journal-title":"Norsk Epidemiol"},{"key":"4167_CR4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.beem.2011.12.001","volume":"26","author":"M Vaxillaire","year":"2012","unstructured":"Vaxillaire M, Bonnefond A, Froguel P (2012) The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis. Best Pract Res Clin Endocrinol Metab 26:171\u2013187","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4167_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1464-5491.2000.00305.x","volume":"17","author":"ER Pearson","year":"2000","unstructured":"Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT (2000) Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1\u03b1 gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 17:543\u2013545","journal-title":"Diabet Med"},{"key":"4167_CR6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","volume":"362","author":"ER Pearson","year":"2003","unstructured":"Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT (2003) Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362:1275\u20131281","journal-title":"Lancet"},{"key":"4167_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7861\/clinmedicine.4-2-144","volume":"4","author":"M Shepherd","year":"2004","unstructured":"Shepherd M, Hattersley AT (2004) \u02bbI don\u02bct feel like a diabetic any more\u02bc: the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing. Clin Med 4:144\u2013147","journal-title":"Clin Med"},{"key":"4167_CR8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1464-5491.2009.02690.x","volume":"26","author":"M Shepherd","year":"2009","unstructured":"Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT (2009) A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 26:437\u2013441","journal-title":"Diabet Med"},{"key":"4167_CR9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2337\/dc11-1243","volume":"35","author":"G Thanabalasingham","year":"2012","unstructured":"Thanabalasingham G, Pal A, Selwood MP et al (2012) Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care 35:1206\u20131212","journal-title":"Diabetes Care"},{"key":"4167_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11892-014-0559-0","volume":"14","author":"RA Ajjan","year":"2014","unstructured":"Ajjan RA, Owen KR (2014) Glucokinase MODY and implications for treatment goals of common forms of diabetes. Curr Diab Rep 14:559","journal-title":"Curr Diab Rep"},{"key":"4167_CR11","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s00125-012-2621-2","volume":"55","author":"W Fendler","year":"2012","unstructured":"Fendler W, Borowiec M, Baranowska-Jazwiecka A et al (2012) Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia 55:2631\u20132635","journal-title":"Diabetologia"},{"key":"4167_CR12","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s00125-013-2916-y","volume":"56","author":"HU Irgens","year":"2013","unstructured":"Irgens HU, Molnes J, Johansson BB et al (2013) Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry. Diabetologia 56:1512\u20131519","journal-title":"Diabetologia"},{"key":"4167_CR13","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1210\/jc.2013-1279","volume":"98","author":"C Pihoker","year":"2013","unstructured":"Pihoker C, Gilliam LK, Ellard S et al (2013) Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab 98:4055\u20134062","journal-title":"J Clin Endocrinol Metab"},{"key":"4167_CR14","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/dc16-0645","volume":"39","author":"M Shepherd","year":"2016","unstructured":"Shepherd M, Shields B, Hammersley S et al (2016) Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care 39:1879\u20131888","journal-title":"Diabetes Care"},{"key":"4167_CR15","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00125-011-2261-y","volume":"54","author":"G Thanabalasingham","year":"2011","unstructured":"Thanabalasingham G, Shah N, Vaxillaire M et al (2011) A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 54:2801\u20132810","journal-title":"Diabetologia"},{"key":"4167_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00125-013-3090-y","volume":"57","author":"T Skrivarhaug","year":"2014","unstructured":"Skrivarhaug T, Stene LC, Drivvoll AK, Strom H, Joner G, Norwegian Childhood Diabetes Study G (2014) Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia 57:57\u201362","journal-title":"Diabetologia"},{"key":"4167_CR17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"Genomes Project C, Abecasis GR, Auton A et al (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491:56\u201365","journal-title":"Nature"},{"key":"4167_CR18","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38, e164","journal-title":"Nucleic Acids Res"},{"key":"4167_CR19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2008","unstructured":"Plon SE, Eccles DM, Easton D et al (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:1282\u20131291","journal-title":"Hum Mutat"},{"key":"4167_CR20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/03014460.2012.759276","volume":"40","author":"PB Juliusson","year":"2013","unstructured":"Juliusson PB, Roelants M, Nordal E et al (2013) Growth references for 0-19 year-old Norwegian children for length\/height, weight, body mass index and head circumference. Ann Hum Biol 40:220\u2013227","journal-title":"Ann Hum Biol"},{"issue":"16 Suppl","key":"4167_CR21","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2164-16-S8-S2","volume":"8","author":"A Frankish","year":"2015","unstructured":"Frankish A, Uszczynska B, Ritchie GR et al (2015) Comparison of GENCODE and RefSeq gene annotation and the impact of reference geneset on variant effect prediction. BMC Genomics 8(16 Suppl):S2","journal-title":"BMC Genomics"},{"key":"4167_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/gm543","volume":"6","author":"DJ McCarthy","year":"2014","unstructured":"McCarthy DJ, Humburg P, Kanapin A et al (2014) Choice of transcripts and software has a large effect on variant annotation. Genome Med 6:26","journal-title":"Genome Med"},{"key":"4167_CR23","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diabetes.53.10.2713","volume":"53","author":"JV Sagen","year":"2004","unstructured":"Sagen JV, Raeder H, Hathout E et al (2004) Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53:2713\u20132718","journal-title":"Diabetes"},{"key":"4167_CR24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00125-013-3075-x","volume":"57","author":"A Stride","year":"2014","unstructured":"Stride A, Shields B, Gill-Carey O et al (2014) Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia 57:54\u201356","journal-title":"Diabetologia"},{"key":"4167_CR25","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.2014.6511","volume":"311","author":"K Estrada","year":"2014","unstructured":"Consortium STD, Estrada K, Aukrust I et al (2014) Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population. JAMA 311:2305\u20132314","journal-title":"JAMA"},{"key":"4167_CR26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1464-5491.2011.03287.x","volume":"28","author":"TJ McDonald","year":"2011","unstructured":"McDonald TJ, Colclough K, Brown R et al (2011) Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from type 1 diabetes. Diabet Med 28:1028\u20131033","journal-title":"Diabet Med"},{"key":"4167_CR27","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2337\/dc11-0323","volume":"34","author":"TJ McDonald","year":"2011","unstructured":"McDonald TJ, Shields BM, Lawry J et al (2011) High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 34:1860\u20131862","journal-title":"Diabetes Care"},{"key":"4167_CR28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2337\/dc10-1293","volume":"34","author":"RE Besser","year":"2011","unstructured":"Besser RE, Shepherd MH, McDonald TJ et al (2011) Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1\u03b1\/hepatocyte nuclear factor 4\u03b1 maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 34:286\u2013291","journal-title":"Diabetes Care"},{"key":"4167_CR29","first-page":"181","volume":"14","author":"RE Besser","year":"2013","unstructured":"Besser RE, Shields BM, Hammersley SE et al (2013) Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes. Pediatr Diabetes 14:181\u2013188","journal-title":"Pediatr Diabetes"},{"key":"4167_CR30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1399-5448.2008.00399.x","volume":"9","author":"JV Sagen","year":"2008","unstructured":"Sagen JV, Bjorkhaug L, Molnes J et al (2008) Diagnostic screening of MODY2\/GCK mutations in the Norwegian MODY Registry. Pediatr Diabetes 9:442\u2013449","journal-title":"Pediatr Diabetes"},{"key":"4167_CR31","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2337\/db05-1513","volume":"55","author":"JV Sagen","year":"2006","unstructured":"Sagen JV, Odili S, Bjorkhaug L et al (2006) From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes 55:1713\u20131722","journal-title":"Diabetes"},{"key":"4167_CR32","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM200105243442104","volume":"344","author":"PR Njolstad","year":"2001","unstructured":"Njolstad PR, Sovik O, Cuesta-Munoz A et al (2001) Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588\u20131592","journal-title":"N Engl J Med"},{"key":"4167_CR33","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2337\/dc11-2420","volume":"35","author":"NL Beer","year":"2012","unstructured":"Beer NL, Osbak KK, van de Bunt M et al (2012) Insights into the pathogenicity of rare missense GCK variants from the identification and functional characterization of compound heterozygous and double mutations inherited in cis. Diabetes Care 35:1482\u20131484","journal-title":"Diabetes Care"},{"key":"4167_CR34","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.90.5.1932","volume":"90","author":"M Gidh-Jain","year":"1993","unstructured":"Gidh-Jain M, Takeda J, Xu LZ et al (1993) Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure\/function relationships. Proc Natl Acad Sci U S A 90:1932\u20131936","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4167_CR35","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1742-4658.2008.06391.x","volume":"275","author":"J Molnes","year":"2008","unstructured":"Molnes J, Bjorkhaug L, Sovik O, Njolstad PR, Flatmark T (2008) Catalytic activation of human glucokinase by substrate binding: residue contacts involved in the binding of D-glucose to the super-open form and conformational transitions. FEBS J 275:2467\u20132481","journal-title":"FEBS J"},{"key":"4167_CR36","volume":"7","author":"CM Garcia-Herrero","year":"2012","unstructured":"Garcia-Herrero CM, Rubio-Cabezas O, Azriel S et al (2012) Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing. PLoS One 7, e30518","journal-title":"PLoS One"},{"key":"4167_CR37","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/humu.21110","volume":"30","author":"KK Osbak","year":"2009","unstructured":"Osbak KK, Colclough K, Saint-Martin C et al (2009) Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 30:1512\u20131526","journal-title":"Hum Mutat"},{"key":"4167_CR38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1006\/bbrc.2000.4024","volume":"279","author":"L Bjorkhaug","year":"2000","unstructured":"Bjorkhaug L, Ye H, Horikawa Y, Sovik O, Molven A, Njolstad PR (2000) MODY associated with two novel hepatocyte nuclear factor-1\u03b1 loss-of-function mutations (P112L and Q466X). Biochem Biophys Res Commun 279:792\u2013798","journal-title":"Biochem Biophys Res Commun"},{"key":"4167_CR39","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2337\/diab.46.6.1081","volume":"46","author":"MA Glucksmann","year":"1997","unstructured":"Glucksmann MA, Lehto M, Tayber O et al (1997) Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes 46:1081\u20131086","journal-title":"Diabetes"},{"key":"4167_CR40","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ng.2794","volume":"45","author":"J Flannick","year":"2013","unstructured":"Flannick J, Beer NL, Bick AG et al (2013) Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nat Genet 45:1380\u20131385","journal-title":"Nat Genet"},{"key":"4167_CR41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1046\/j.1464-5491.1999.00188.x","volume":"16","author":"MC Ng","year":"1999","unstructured":"Ng MC, Cockburn BN, Lindner TH et al (1999) Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1\u03b1 genes in patients with early-onset type 2 diabetes mellitus\/MODY. Diabet Med 16:956\u2013963","journal-title":"Diabet Med"},{"key":"4167_CR42","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2337\/diab.46.3.528","volume":"46","author":"PJ Kaisaki","year":"1997","unstructured":"Kaisaki PJ, Menzel S, Lindner T et al (1997) Mutations in the hepatocyte nuclear factor-1\u03b1 gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46:528\u2013535","journal-title":"Diabetes"},{"key":"4167_CR43","first-page":"1691","volume":"383","author":"H Thomas","year":"2002","unstructured":"Thomas H, Badenberg B, Bulman M et al (2002) Evidence for haploinsufficiency of the human HNF1\u03b1 gene revealed by functional characterization of MODY3-associated mutations. Biol Chem 383:1691\u20131700","journal-title":"Biol Chem"},{"key":"4167_CR44","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2002-020945","volume":"88","author":"L Bjorkhaug","year":"2003","unstructured":"Bjorkhaug L, Sagen JV, Thorsby P, Sovik O, Molven A, Njolstad PR (2003) Hepatocyte nuclear factor-1\u03b1 gene mutations and diabetes in Norway. J Clin Endocrinol Metab 88:920\u2013931","journal-title":"J Clin Endocrinol Metab"},{"key":"4167_CR45","first-page":"1231","volume":"47","author":"K Yamagata","year":"1998","unstructured":"Yamagata K, Yang Q, Yamamoto K et al (1998) Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1\u03b1 is dominant negative. Diabetes 47:1231\u20131235","journal-title":"Diabetes"},{"key":"4167_CR46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/1098-1004(200009)16:3<273::AID-HUMU18>3.0.CO;2-Z","volume":"16","author":"S Ellard","year":"2000","unstructured":"Ellard S, Bulman MP, Frayling TM, Shepherd M, Hattersley AT (2000) Proposed mechanism for a novel insertion\/deletion frameshift mutation (I414G415ATCG\u2009\u2192\u2009CCA) in the hepatocyte nuclear factor 1 alpha (HNF-1\u03b1) gene which causes maturity-onset diabetes of the young (MODY). Hum Mutat 16:273","journal-title":"Hum Mutat"},{"key":"4167_CR47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/humu.22279","volume":"34","author":"K Colclough","year":"2013","unstructured":"Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S (2013) Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Hum Mutat 34:669\u2013685","journal-title":"Hum Mutat"},{"key":"4167_CR48","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1210\/jc.2012-3453","volume":"98","author":"S Ferre","year":"2013","unstructured":"Ferre S, Bongers EM, Sonneveld R et al (2013) Early development of hyperparathyroidism due to loss of PTH transcriptional repression in patients with HNF1\u03b2 mutations? J Clin Endocrinol Metab 98:4089\u20134096","journal-title":"J Clin Endocrinol Metab"},{"key":"4167_CR49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/db07-1467","volume":"57","author":"A Molven","year":"2008","unstructured":"Molven A, Ringdal M, Nordbo AM et al (2008) Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes 57:1131\u20131135","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-4167-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4167-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T06:50:11Z","timestamp":1589698211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-4167-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["4167"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-4167-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}